Miner Lab
@miner_lab
Mechanisms & therapies for rare rheumatic diseases. Chair, Gene Therapy and Vaccines (GTV) Graduate Program @CAMBUPenn @UPenn_I3H @pennmedicine @rvcl_research
ID: 1202748585370095616
https://www.med.upenn.edu/minerlab 06-12-2019 00:36:39
550 Tweet
2,2K Takipçi
2,2K Takip Edilen
Thank you to the Journal of Clinical Investigation for publishing this important corrigendum indicating clear disease progression in RVCL patients treated with crizanlizumab. This was key primary endpoint data, crucial for treatment decisions made by patients and their providers.